ERd Combination Treatment in Newly Diagnosed Multiple Myeloma

NCT06997081 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

104

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Lenalidomide
DRUG: Dexamethasone
DRUG: Elranatamab

Sponsor

University of Miami

Collaborators

[object Object]